ARGX: argenx N.V. Sotuvga nisbatan narx
argenx SE (ARGX) noyob llama antitelalari yordamida autoimmun patologiya terapiyalarini ishlab chiqishda yetakchilik qilmoqda. FDA ning qat'iy nazorati va patent himoyasi raqobatchilar uchun kirishning mustahkam to'sig'ini yaratadi. Dorilarning global miqyosda ishga tushirilishi foyda o'sishini va R&D investitsiyalarining qaytishini tezlashtirmoqda. Daromad koeffitsiyenti tendentsiyasi biznesning bozor tomonidan qayta baholanishini ko'rsatadi, bunda ko'rsatkich 11.80 ga yetdi.
Argenx (ARGX) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati argenx SE|ARGX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati argenx BVBA|ARGX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Argenx|ARGX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi argenx|Oraliq qoplash koeffitsiyenti argenx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ARGX - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi argenx SE|ARGX - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati argenx N.V.|ARGX - PEG multiplikatori|EV/EBITDA multiplikatori Argenx|ARGX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda argenx|ARGX - Bir aksiya uchun sof foyda (EPS TTM)|Sirpanuvchi yil uchun bir aksiya uchun sof foyda o'sishi argenx.com|ARGX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati argenx SE
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:argenx.com (ARGX)
Emitent ishonchliligini tekshirishda ushbu ko'rsatkich investor daromadning bir birligi uchun qancha to'layotganini aniqlash uchun bozor kapitalizatsiyasini savdo hajmi bilan solishtiradi. Kompaniya qiymatining yillik daromadga nisbati xarid xarajatlarining ta'sirini istisno qilgan holda va texnologik antitelolarni litsenziyalash ittifoqlaridan olinadigan daromadga e'tibor qaratgan holda argenx SE dori vositalarining tijoratlashtirish samaradorligini baholash imkonini beradi.
argenx SE kimlar bilan raqobatlashadi
biontech.de - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ABVX (Abivax S.A.)|ADMA Biologics Inc (ADMA) - Sotuvga nisbatan narx|Protagonist Therapeutics Inc - P/S multiplikatori|IMVT - P/S multiplikatori|Kiniksa Pharmaceuticals (KNSA) - Narxning daromadga nisbati|grifols.com - Bozor kapitallashuvining daromadga nisbati|ADPT (Adaptive Biotechnologies Corporation) - P/S multiplikatori|CLDX - Narx/daromad multiplikatori|P/S multiplikatori AUPH|BCRX - Sotuvga nisbatan narx|Narxning daromadga nisbati Vera Therapeutics, Inc. VERA|DNTH: Kapitalizatsiya va daromad nisbati|PHVS: Kapitalizatsiyaning daromadga nisbati|ABCL (AbCellera Biologics Inc.) - Kapitalizatsiya va daromad nisbati|TRML (Tourmaline Corp) - Kapitalizatsiyaning daromadga nisbati|Precigen Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Pharming Group N.V.|nektar.com (NKTR) - Narx/daromad koeffitsiyenti|P/S multiplikatori UPB|ZBIO - Sotuvga nisbatan narx|P/S multiplikatori IMNM (Immunome Corp)|P/S multiplikatori Gossamer Bio Corp. GOSS|KALV - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SEPN (septerna.com)|PVLA: P/S multiplikatori|Narx/daromad multiplikatori Savara Inc SVRA|Kapitalizatsiyaning daromadga nisbati RIGL|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio Inc.)|Narxning daromadga nisbati Astria Therapeutics (ATXS)|ENGN: Narxning sotuvga nisbati|P/S multiplikatori RAPT (RAPT Therapeutics)|Bozor kapitallashuvining daromadga nisbati JBIO|Aclaris - P/S multiplikatori|KYTX - P/S multiplikatori|Tiziana Life Sciences (TLSA) - Narxning daromadga nisbati|cabalettabio.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Ventyx Biosciences, Inc.|Kapitalizatsiyaning daromadga nisbati Theratechnologies, Inc. (THTX)|P/S multiplikatori AVTX|P/S multiplikatori Eledon Pharmaceuticals, Inc (ELDN)|Agenus - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CLYM|Zura Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti aTyr Pharma Inc ATYR|adagene.com (ADAG) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ikena Oncology|Narxning daromadga nisbati Shattuck Labs Inc|Kapitalizatsiyaning daromadga nisbati Equillium Bio (EQ)|Kapitalizatsiyaning daromadga nisbati CNTB (Connect Biopharma)|P/S multiplikatori immunic-therapeutics.com (IMUX)|Narxning daromadga nisbati Atara Bio ATRA|IFRX: Kapitalizatsiya va daromad nisbati|X4 Pharmaceuticals - P/S multiplikatori|Sotuvga nisbatan narx Adicet Bio|CELU: P/S multiplikatori|INmune Bio Inc (INMB) - P/S multiplikatori|Narxning daromadga nisbati Barinthus Bio|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|akaritx.com (AKTX) - Narx/daromad multiplikatori|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Sotuvga nisbatan narx|GOVX - Narxning daromadga nisbati|EDSA (Edesa Biotech Corp) - Kapitalizatsiya va daromad nisbati|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati CARM|Kapitalizatsiyaning daromadga nisbati XTLB|BOLT: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Narx/daromad koeffitsiyenti aptevotherapeutics.com|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|Aditxt Inc. (ADTX) - Sotuvga nisbatan narx|GRI Bio - P/S multiplikatori|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|INDP (Indaptus Therapeutics) - P/S multiplikatori|SCNI - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|affimed.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Allakos ALLK|HOOK (HOOKIPA Pharma, Inc.) - Narxning sotuvga nisbati|IGM Bio - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ITOS (iteostherapeutics.com)|OCEA: P/S multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - P/S multiplikatori|Narxning daromadga nisbati Third Harmonic Bio, Inc
